Abstract

POLYPHARMACY: - A BRIEF SYSTEMATIC REVIEW

Dr. Virendra Kushwaha, Dr. Pooja Agrawal*, Dr. Vipul Sukla, Dr. Arka Das and Dr. B. K. Shoraisham

Abstract

Polypharmacy is a preventable and significant contributor to morbidity and mortality in the geriatric population. To effectively treat polypharmacy and avoid ADE in patients down the road, a multipronged strategy based on evidence-based therapies is required. Targeting people, circumstances, and prescribing practices associated with a higher risk of having an adverse drug event is important. Liberalizing clinical aims for elderly patients and incorporating ideas from palliative care can open the door for logically stopping a number of drugs. Interdisciplinary teams and treatment models that have been shown to be successful in reducing polypharmacy use several of these tactics.

Keywords: Medications, Adverse Drug Events, Elderly, Drug interactions.